Neuronetics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| STIM | BWAY | NPCE | NMTC | ECOR | MOBI | |
|---|---|---|---|---|---|---|
| Market cap | 206.11M | 451.24M | 457.89M | 8.65M | 75.73M | 374.19M |
| P/E (TTM) | — | 48.7 | — | — | — | — |
| Forward P/E | -8.0 | 22.1 | -61.3 | -3.4 | -15.3 | -5.1 |
| Price/book | 8.3 | 5.7 | 38.4 | 2.2 | -27.1 | 2.2 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −17.52% | +37.91% | −5.16% | −77.98% | +52.53% | −15.15% |
| Today | +19.69% | +0.54% | +8.37% | −3.06% | +16.18% | +12.74% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All STIM news ›Neuronetics outlines $160M-$164M 2026 revenue outlook while targeting limited to no net cash utilization in H2
Neuronetics Q3 2026 earnings: revenue rose 12%, margins improved, and cash flow strengthened. Earnings Call Insights: Neuronetics (STIM) Q3 2026 - CEO Daniel Reuvers said the company “continue[s] to execute against the profitability and…
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635
Investing News Network Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635 Restricted stock units ("RSUs") The NeuroStar Advanced Therapy System is cleared by the U.S. Food and Drug Administration for adults with M
Neuronetics, Inc. (STIM) Q3 2026 Earnings Call Transcript
Neuronetics, Inc. (STIM) Q3 2026 Earnings Call November 4, 2026 8:30 AM EST Daniel Reuvers - CEO, President & DirectorNir Naor - Executive VP, CFO, Corporate Secretary, Principal Financial and Accounting Officer & Treasurer Aman PatelJohn…
Neuronetics (STIM) & Its Competitors Head to Head Comparison
Posted by Sarita Garza on Nov 3rd, 2026 Neuronetics (NASDAQ:STIM – Get Free Report) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its competitors? We will compare Neuronetics…
Comparing Curaleaf (OTCMKTS:CURLF) & Neuronetics (NASDAQ:STIM)
Posted by Michael Walen on Oct 31st, 2026 Neuronetics (NASDAQ:STIM – Get Free Report) and Curaleaf (OTCMKTS:CURLF – Get Free Report) are both healthcare companies, but which is the better business? We will compare the two companies based…
Neuro Care Network
The Neuro Care Network is a collaboration between MSU Health Care and University of Michigan Health to enhance access to advanced neurologic care close to home for families in mid-Michigan. We’ve joined forces to improve care for patients…
Neuronetics to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call
The Manila Times MALVERN, Pa., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patien
NeuroRPM Becomes an athenahealth Solution Partner, Now Available in the athenahealth Marketplace
WASHINGTON, Oct. 06, 2026 (GLOBE NEWSWIRE) -- NeuroRPM, a provider of FDA-cleared, AI-enabled wearable technology for remote monitoring of Parki... NeuroRPM Becomes an athenahealth Solution Partner, Now Available in the athenahealth…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- investingnews.com2
- seekingalpha.com2
- themarketsdaily.com2
- manilatimes.net1
- markets.businessinsider.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 8 articles, not a forecast.